Shield Therapeutics PLC Stock
€0.091
Your prediction
Pros and Cons of Shield Therapeutics PLC in the next few years
Pros
Cons
Performance of Shield Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Shield Therapeutics PLC | 2.260% | -1.093% | -12.136% | 182.813% | -13.810% | 47.154% | -82.925% |
| Card Factory plc | -1.530% | 3.207% | -10.380% | -29.200% | -6.842% | -26.708% | -22.198% |
| Pets At Home Group Ls 1 | 0.190% | 2.476% | -4.694% | -22.422% | -6.272% | -48.713% | -56.960% |
| Natural Grocers By Vit. Cot. | 0.000% | -0.885% | 2.752% | -41.053% | 4.673% | 124.000% | 58.865% |
News
What Is the "Achilles Shield" and How Is Lockheed Martin Involved? Here's What Investors Need to Know.
Greece's air-defense capabilities will soon be getting an upgrade. That's the chief takeaway from the country's recent vote by the Special Permanent Parliamentary Committee on Armaments Programs and
5 Stocks and ETFs to Help Shield Your Portfolio During Volatility
The U.S. stock market has gotten off to an unsteady start this year. Outside a handful of defensive pockets, such as consumer staples and energy, most investors have felt the pressure. Elevated
Why Guardant Health Stock Surged Today
Shares of Guardant Health (NASDAQ: GH) rocketed 28% higher on Thursday after the precision oncology company reported outstanding growth metrics across its key product lines.
Image source: Getty


